Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System
- Recalling company
- Teva Pharmaceuticals USA, Inc
- Product
- Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch
- Reason
- CGMP Deviations: use of an unapproved raw material
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Mar 19, 2026
- Reported
- Apr 15, 2026
- Distribution
- Within U.S
- Status
- Ongoing
- Quantity
- 113,943 Cartons
- Lot / codes
- Lot: 100053892, Exp.: 04/2026; 100057899, Exp.: 05/2026; 100062704, Exp.: 02/2027.
- Company location
- Parsippany, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0474-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0474-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.